Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease

Journal of Visualized Experiments

Volumn , Issue 60, 2012, Pages

  Thiele, Sherri L ^a   Warre, Ruth ^a   Nash, Joanne E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

6 OHDA; Issue 60; Medial forebrain bundle; Medicine; Mouse; Parkinson's disease; Unilateral

Indexed keywords

EID: 84857869793     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3234     Document Type: Article

References (31)

1. Costall, B., Naylor, R.J., & Pycock, C. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. Eur. J. Pharmacol. 35, 276-283 (1976).
2. Maneuf, Y.P., Mitchell, I.J., Crossman, A.R., & Brotchie, J.M. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp. Neurol. 125, 65-71, doi:S0014-4886(84)71007-7 [pii] 10.1006/exnr.1994.1007 (1994).
3. Robertson, G.S. & Robertson, H.A. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J. Neurosci. 9, 3326-3331 (1989).
4. Ungerstedt, U. & Arbuthnott, G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493, doi:0006-8993(70)90187-3 [pii] (1970).
5. Brotchie, J.M. Novel approaches to the symptomatic treatment of parkinsonian syndromes: alternatives and adjuncts to dopamine-replacement. Curr. Opin. Neurol. 10, 340-345 (1997).
6. Besson, M.J., Graybiel, A.M., & Nastuk, M.A. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience. 26, 101-119 (1988).
7. Gerfen, C.R., et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250, 1429-1432 (1990).
8. Schiffmann, S.N., Jacobs, O., & Vanderhaeghen, J.J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57, 1062-1067 (1991).
9. Hutchison, W.D., et al. Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients. Neuroreport. 5, 1533-1537 (1994).
10. Pan, H.S., Penney, J.B., & Young, A.B. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J. Neurochem. 45, 1396-1404 (1985).
11. Pan, H.S. & Walters, J.R. Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat. Synapse. 2, 650-656, doi:10.1002/syn.890020612 (1988).
12. Gong, S., et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature. 425, 917-925, doi:10.1038/nature02033 [pii] nature02033 (2003).
13. Kreitzer, A.C. & Malenka, R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature. 445, 643-647 (2007).
14. Shen, W., Flajolet, M., Greengard, P., & Surmeier, D.J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science. 321, 848-851, doi:321/5890/848 [pii] 10.1126/science.1160575 (2008).
15. Lundblad, M., Picconi, B., Lindgren, H., & Cenci, M.A. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 16, 110-123 (2004).
16. Grealish, S., Mattsson, B., Draxler, P., & Bjorklund, A. Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. Eur. J. Neurosci. 31, 2266-2278, doi:EJN7265 [pii] 10.1111/j.1460-9568.2010.07265.x (2010).
17. Dauer, W. & Przedborski, S. Parkinson's disease: mechanisms and models. Neuron. 39, 889-909, doi:S0896627303005683 [pii] (2003).
18. Francardo, V., et al. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol. Dis. 42, 327-340, doi:S0969-9961(11)00045-3 [pii] 10.1016/j.nbd.2011.01.024 (2011).
19. Jakowec, M.W. & Petzinger, G.M. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates. Comp. Med. 54, 497-513 (2004).
20. Visanji, N.P. & Brotchie, J.M. MPTP-Induced Models of Parkinson's Disease in Mice and Non-Human Primates. Curr. Protoc. Pharmacol. Chapter 5, Unit5 42, doi:10.1002/0471141755.ph0542s29 (2005).
21. Sedelis, M., Schwarting, R.K., & Huston, J.P. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav. Brain Res. 125, 109-125, doi:S0166-4328(01)00309-6 [pii] (2001).
22. Schallert, T., Fleming, S.M., Leasure, J.L., Tillerson, J.L., & Bland, S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology. 39, 777-787, doi:S0028390800000058 [pii] (2000).
23. Paul, M.L., Currie, R.W., & Robertson, H.A. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. Neuroscience. 66, 347-359, doi:0306-4522(94)00582-P [pii] (1995).
24. Breese, G.R. & Traylor, T.D. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons. J. Pharmacol Exp. Ther. 174, 413-420 (1970).
25. Breese, G.R., Chase, T.N., & Kopin, I.J. Metabolism of tyramine-3H and octopamine-3H by rat brain. Biochem. Pharmacol. 18, 863-869, doi:0006-2952(69)90057-4 [pii] (1969).
26. Frankin, K.B.J. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates. (2008).
27. Cornell-Bell, A.H., Finkbeiner, S.M., Cooper, M.S., & Smith, S.J. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science. 247, 470-473 (1990).
28. Iancu, R., Mohapel, P., Brundin, P., & Paul, G. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav. Brain Res. 162, 1-10, doi:S0166-4328(05)00070-7 [pii] 10.1016/j.bbr.2005.02.023 (2005).
29. Tan, Y., Williams, E.A., Lancia, A.J., & Zahm, D.S. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat. Brain Res. 869, 56-68, doi:S0006-8993(00)02348-9 [pii] (2000).
30. Thiele, S.L., et al. Generation of a model of L-DOPA-induced dyskinesia in two different mouse strains. J. Neurosci. Methods. 197, 193-208, doi:S0165-0270(11)00087-2 [pii] 10.1016/j.jneumeth.2011.02.012 (2011).
31. Henry, B., Crossman, A.R., & Brotchie, J.M. Characterization of a rodent model in which to investigate the molecular and cellular mechanisms underlying the pathophysiology of L-dopa-induced dyskinesia. Adv. Neurol. 78, 53-61 (1998).